Michael E. Prevoznik
Senior Vice President And General Counsel
Quest Diagnostics Inc · DGX
$2.6M
Reported total · FY2025 · SCT Total as filed
Source: DEF 14A filed April 6, 2026. Prior years are from that filing's three-year table.
Catalog as of September 15, 2026. Not a live market feed.
- Salary
- $550K
- Stock Awards
- $1.1M
- Option Awards
- $387K
- Incentives
- $438K
- Other
- $56K
Compensation History
| Fiscal Year | Salary | Stock Awards | Total Compensation |
|---|---|---|---|
| 2025 | $550,000 | $1,132,015 | $2,563,593 |
| 2024 | $550,000 | $1,086,688 | $2,428,646 |
| 2023 | $542,500 | $1,020,747 | $2,251,920 |
Current Position
- Company
- Quest Diagnostics Inc
- Title
- Senior Vice President And General Counsel
- Ticker
- DGX · NYSE
- Fiscal Year
- 2025
SEC Sources
Fiscal years below are columns from the latest DEF 14A Summary Compensation Table (filed April 6, 2026), not separate historical filings.
| Fiscal Year | Source |
|---|---|
| 2025 | View SEC filing |
| 2024 | View SEC filing |
| 2023 | View SEC filing |
Accession 0001140361-26-013356.
Other Quest Diagnostics Executives
James E. Davis
Chairman, Chief Executive Officer And President
Quest Diagnostics · DGX
$15.5M
FY 2025 · DEF 14A
Sam A. Samad
Executive Vice President And Chief Financial Officer
Quest Diagnostics · DGX
$4.4M
FY 2025 · DEF 14A
Catherine T. Doherty
Executive Vice President, Regional Businesses
Quest Diagnostics · DGX
$3.6M
FY 2025 · DEF 14A
Karthik Kuppusamy
Senior Vice President, Clinical Solutions
Quest Diagnostics · DGX
$2.6M
FY 2025 · DEF 14A